MiRNA-based therapy for glucose intolerance and insulin resistance: MiR-23b-3p increases ß-cell mass and function via down regulation of its target gene, 8/June/2014, 5.05 am

Mechanistic and Therapeutic insights into the suppression of Myeloproliferative neoplasms (MPN): NR2F2 suppresses the expression of MPL via up regulation of its target gene, 7/June/2014, 9.08 am
June 7, 2014
Insights into the treatment of Pulmonary Hypertension: BMP4 increases the expression of dimethylarginine dimethylaminohydrolases (DDAH1) via down regulation of its target miRNA, 8/June/2014, 5.08 am
June 7, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan PhD

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, L, MiRNA-based therapy for glucose intolerance and insulin resistance: MiR-23b-3p  increases  ß-cell mass and function via down regulation of its target gene, 8/June/2014, 5.05 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.